Literature DB >> 30175661

Intensive blood pressure lowering prevents mild cognitive impairment and possible dementia and slows development of white matter lesions in brain: the SPRINT Memory and Cognition IN Decreased Hypertension (SPRINT MIND) study.

Sverre E Kjeldsen1, Krzysztof Narkiewicz2, Michel Burnier3, Suzanne Oparil4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30175661     DOI： 10.1080/08037051.2018.1507621

Source DB:  PubMed          Journal:  Blood Press        ISSN： 0803-7051            Impact factor:   2.835


× No keyword cloud information.
  20 in total

1.  Cognitive Function, Access to Kidney Transplantation, and Waitlist Mortality Among Kidney Transplant Candidates With or Without Diabetes.

Authors:  Nadia M Chu; Zhan Shi; Christine E Haugen; Silas P Norman; Alden L Gross; Daniel C Brennan; Michelle C Carlson; Dorry L Segev; Mara A McAdams-DeMarco
Journal:  Am J Kidney Dis       Date:  2020-02-03       Impact factor: 8.860

2.  Cardiometabolic Health and Longitudinal Progression of White Matter Hyperintensity: The Mayo Clinic Study of Aging.

Authors:  Eugene L Scharf; Jonathan Graff-Radford; Scott A Przybelski; Timothy G Lesnick; Michelle M Mielke; David S Knopman; Gregory M Preboske; Christopher G Schwarz; Matthew L Senjem; Jeffrey L Gunter; Mary Machulda; Kejal Kantarci; Ronald C Petersen; Clifford R Jack; Prashanthi Vemuri
Journal:  Stroke       Date:  2019-09-12       Impact factor: 7.914

3.  Rationale and methods for a multicenter clinical trial assessing exercise and intensive vascular risk reduction in preventing dementia (rrAD Study).

Authors:  Amanda N Szabo-Reed; Eric Vidoni; Ellen F Binder; Jeffrey Burns; C Munro Cullum; William P Gahan; Aditi Gupta; Linda S Hynan; Diana R Kerwin; Heidi Rossetti; Ann M Stowe; Wanpen Vongpatanasin; David C Zhu; Rong Zhang; Jeffrey N Keller
Journal:  Contemp Clin Trials       Date:  2019-03-01       Impact factor: 2.226

4.  Nighttime Blood Pressure Interacts with APOE Genotype to Increase the Risk of Incident Dementia of the Alzheimer's Type in Hispanics.

Authors:  Jesus D Melgarejo; Daniel C Aguirre-Acevedo; Ciro Gaona; Carlos A Chavez; Gustavo E Calmón; Eglé R Silva; Gabriel A de Erausquin; Mario Gil; Luis J Mena; Joseph D Terwilliger; Humberto Arboleda; Nikolaos Scarmeas; Joseph H Lee; Gladys E Maestre
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 5.  Cognitive Impairment in Older Adults and Therapeutic Strategies.

Authors:  Thomas J Montine; Syed A Bukhari; Lon R White
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

6.  Impact of Guidelines on Hypertension Control in the Elderly.

Authors:  Del Pinto Rita; Mirela Dobre; Silvia Pagliacci; Claudio Ferri
Journal:  Curr Pharm Des       Date:  2021       Impact factor: 3.310

7.  Right hippocampal volume mediation of subjective memory complaints differs by hypertension status in healthy aging.

Authors:  Emily J Van Etten; Pradyumna K Bharadwaj; Lauren A Nguyen; Georg A Hishaw; Theodore P Trouard; Gene E Alexander
Journal:  Neurobiol Aging       Date:  2020-06-19       Impact factor: 5.133

8.  Volume of white matter hyperintensities increases with blood pressure in patients with hypertension.

Authors:  Yu Zhao; Zunyu Ke; Wenbo He; Zhiyou Cai
Journal:  J Int Med Res       Date:  2019-06-26       Impact factor: 1.671

Review 9.  Magnetic Resonance Imaging in Childhood Primary Hypertension: Potential in the Study of Cognitive Outcomes.

Authors:  Md Nasir Uddin; Madalina Tivarus; Heather Adams; Erika Little; Giovanni Schifitto; Marc B Lande
Journal:  Hypertension       Date:  2021-02-10       Impact factor: 10.190

10.  Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis.

Authors:  Jean K Ho; Frank Moriarty; Jennifer J Manly; Eric B Larson; Denis A Evans; Kumar B Rajan; Elizabeth M Hudak; Lamiaa Hassan; Enwu Liu; Nobuyuki Sato; Naoyuki Hasebe; Danielle Laurin; Pierre-Hugues Carmichael; Daniel A Nation
Journal:  Hypertension       Date:  2021-06-21       Impact factor: 9.897
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.